Evidence map›Paper›PMID 27795831›Full record

ArticleJournal of pharmaceutical policy and practice2016

Impact of switching from intravenous to oral linezolid therapy in Japanese patients: a retrospective cohort study.

Akihiro Tanaka, Akiko Yano, Shinichi Watanabe, Mamoru Tanaka, Hiroaki Araki

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Transitioning to oral therapy compared to IV inAnnals of medicine and surgery (2012) · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Akihiro TanakaDivision of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime 791-0295 Japan.
Akiko YanoDivision of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime 791-0295 Japan.
Shinichi WatanabeDivision of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime 791-0295 Japan.
Mamoru TanakaDivision of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime 791-0295 Japan.
Hiroaki ArakiDivision of Pharmacy, Ehime University Hospital, 454 Shitsukawa, Toon, Ehime 791-0295 Japan.
Ehime University Hospital · JPEhime University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh oral bioavailability of antimicrobial agents can result in the replacement of intravenous (IV) therapy with oral therapy when a patient meets defined clinical criteria. However, few studies have evaluated the effects of switching antibiotic administration route in Japan, especially for linezolid. This study evaluated an IV-to-oral antibiotic switching program for linezolid treatment at a university hospital in Japan.

methodsIn a retrospective cohort study of 73 patients, we assessed the efficacy and safety of IV-to-oral linezolid therapy (

resultsDuration of linezolid treatment, changes in C-reactive protein or platelet count from baseline, re-administration of anti-methicillin-resistant

conclusionsAn IV-to-oral switching program could reduce the duration of IV linezolid therapy without worsening clinical outcomes in Japanese patients receiving linezolid therapy.

Indexed as

CostLinezolidSwitching therapy

Identifiers

PMID27795831
PMCPMC5084316
OpenAlexW2542439917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.